0001246360-13-003431.txt : 20130701
0001246360-13-003431.hdr.sgml : 20130701
20130701170715
ACCESSION NUMBER: 0001246360-13-003431
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130628
FILED AS OF DATE: 20130701
DATE AS OF CHANGE: 20130701
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SYNAGEVA BIOPHARMA CORP
CENTRAL INDEX KEY: 0000911326
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 561808663
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 33 HAYDEN AVE.
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: (781) 357-9900
MAIL ADDRESS:
STREET 1: 33 HAYDEN AVE.
CITY: LEXINGTON
STATE: MA
ZIP: 02421
FORMER COMPANY:
FORMER CONFORMED NAME: TRIMERIS INC
DATE OF NAME CHANGE: 19970516
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Goldberg Mark Alan
CENTRAL INDEX KEY: 0001532475
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23155
FILM NUMBER: 13945488
MAIL ADDRESS:
STREET 1: 128 SPRING STREET, SUITE 520
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
form.xml
PRIMARY DOCUMENT
X0306
4
2013-06-28
false
0000911326
SYNAGEVA BIOPHARMA CORP
GEVA
0001532475
Goldberg Mark Alan
33 HAYDEN AVE
LEXINGTON
MA
02421
false
true
false
false
SVP,Medical&Regulatory Affairs
Common Stock
2013-06-28
5
A
false
267
35.68
A
267
D
The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the Synageva BioPharma Corp. Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of January 1, 2013 through June 30, 2013. This transaction is also exempt under Rule 16b-3(c).
The Option Period (as defined in the ESPP) ended on June 30, 2013, so the shares were acquired on June 28, 2013, the last trading day prior to the end of the Option Period.
In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on June 28, 2013.
/s/ Mark Goldberg
2013-07-01